Dolgin, Elie <br/><br/>
With bated breath, companies await approval for inhalable drugs.  [electronic resource] 

 -  Nature medicine  Feb 2012 
 - 183 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>1546-170X 
<br/><br/><label>Standard No.: </label>10.1038/nm0212-183  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Drug Approval<br/>Humans<br/>Lung Diseases--drug therapy<br/>United States<br/>United States Food and Drug Administration